Antisense RNAi Therapeutics Market Analysis Trends Forecast and Segmentation

1
PharmaSphere Emerging Biotechnologies - Antisense
RNAi Therapeutics Market Analysis
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• PharmaSphere Emerging Biotechnologies Antisense
  RNAi Therapeutics Market Analysis report is an
  essential source of information and analysis on
  the RNA interference (RNAi) therapy field. Using
  detailed company data, deal analysis, corporate
  strategy, and market trends, GlobalData provides
  an in-depth analysis of the current and future
  growth drivers of the RNAi therapy market. The
  report discusses the key factors shaping and
  driving the RNAi therapy business, and provides
  insights into the competitive landscape and
  emerging strategies expected to significantly
  influence the market positions of companies
  currently involved in the development and
  commercialization of RNAi therapeutics.
• Scope
• This report provides market developments across
  the RNAi therapy field, including clinical
  trials, deals, and pipeline investments
• Investment examined from both industry and
  financial communities
• Clinical trials activity examined across phase of
  development, therapy area, and indication.
• This report offers a deep dive into the synergies
  behind partnering and acquisition activities
• Deals examined across geography, entity type,
  company, financial advisor, phase of development,
  therapy area, indication, and mechanism of action
• Pipeline profiles of 25 leading biotech companies
  developing RNAi therapeutics
• Read More At http//www.researchbeam.com/pharmas
  phere-emerging-biotechnologies-antisense-rnai-ther
  apeutics-analysis-market

3


Table of Content
1 Table of Contents 6 1.1 List of Tables 9 1.2
List of Figures 11 2 Introduction 13 2.1 Report
Scope 13 2.2 Companies Mentioned 14 3 Antisense
RNAi Therapy Overview 15 3.1 What is Antisense
Therapy? 15 3.2 The Second Era of RNAi 17 4
Clinical Trials 19 4.1 Overview 19 4.2 Company
20 5 Company Analysis 36 5.1 Overview 36 5.2
Pipeline Profiles 39 6 Deals Landscape 88 6.1
Overview 88 6.2 Deal Type 103 7 Strategic Outlook
119 8 Appendix 120 8.1 Bibliography 120 8.2
Research Methodology 120 Enquire At
http//www.researchbeam.com/pharmasphere-emerging-
biotechnologies-antisense-rnai-therapeutics-analys
is-market/enquire-about-report
4


Report Overview
Key Questions Answered What are the drivers of
the RNAi therapy field? Who are the leading
companies involved in the development of RNAi
therapies? What are the major trends in RNAi
clinical trials? What specific therapeutic areas
and indications are receiving the most clinical
research? What specific business development
activities are taking place in terms of
partnerships or mergers and acquisitions
(MAs)? Has investor confidence been restored in
the antisense/RNAi therapy field? Reasons to
buy Identify the key players in the RNAi
market. Analyze and track the strategies that
companies are using to strengthen their position
in the RNAi therapy field independent source for
due diligence. Organize your sales and marketing
strategy to identify companies with proprietary
technologies in order to maximize opportunities
for licensing, partnership, investment, or
takeover. Understand the flow of investment from
capital markets into the RNAi therapy field.
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/pharmasphere-emerging-
biotechnologies-antisense-rnai-therapeutics-analys
is-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com